Risk perception after CF carrier testing and impact of the test result on reproductive decision making

American Journal of Medical Genetics

Volumn 69, Issue 4, 1997, Pages 422-428

  Denayer, Lieve ^a   Welkenhuysen, Myriam ^a   Evers Kiebooms, Gerry ^a   Cassiman, Jean Jacques ^a   Van Den Berghe, Herman ^a  

^a CENTER FOR HUMAN GENETICS   (Belgium)

Author keywords

carrier status; cystic fibrosis; genetic testing; heterozygote detection

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DECISION MAKING; FEMALE; GENETIC RISK; HETEROZYGOTE DETECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PREGNANCY; PRIORITY JOURNAL; RISK ASSESSMENT;

ADOLESCENT; ADULT; CYSTIC FIBROSIS; DECISION MAKING; FEMALE; GENETIC SCREENING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HETEROZYGOTE; HUMANS; MALE; QUESTIONNAIRES; REPRODUCTION; RISK FACTORS;

EID: 0030904547     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19970414)69:4<422::AID-AJMG17>3.0.CO;2-P     Document Type: Article

References (19)

1. Bekker H, Denniss G, Modell M, Bobrow M, Marteau T (1994): The impact of population based screening for carriers of cystic fibrosis. J Med Genet 31:364-368.
2. Cuppens H, Marynen P, De Boeck C, Cassiman JJ (1993): Detection of 98.5% of the mutations in 200 Belgian cystic fibrosis alleles by reverse dot-blot and sequencing of the complete coding region and exon/intron junctions of the CFTR gene. Genomics 18:693-697.
3. Denayer L, De Boeck K, Evers-Kiebooms G, Van den Berghe H (1992): The transfer of information about genetic transmission to brothers and sisters of parents with a CF child. Birth Defects 28:149-158.
4. Denayer L, Welkenhuysen M, Evers-Kiebooms G, Cassiman JJ, Van den Berghe H (1996): The CF carrier status does not cause a diminished self concept or increased anxiety: Results of psychometric testing after at least one year. Clin Genet 49:232-236.
5. Evers-Kiebooms G, Denayer L, Welkenhuysen M, Cassiman JJ, Van den Berghe H (1994): A stigmatizing effect of the carrier status for cystic fibrosis? Clin Genet 46:336-343.
6. Fanos JH, Johnson JP (1995a): Barriers to carrier testing for adult cystic fibrosis sibs: The importance of not knowing. Am J Med Genet 59:85-91.
7. Fanos JH, Johnson JP (1995b): Perception of Carrier Status by Cystic Fibrosis Siblings. Am J Hum Genet 57:431-438.
8. Kaplan F, Clow CL, Scriver CR (1994): Cystic fibrosis carrier screening by DNA analysis: a pilot study of attitudes among participants. Am J Hum Genet 49:240-242.
9. Mennie ME, Gilfillan A, Compton M, Curtis L, Liston WA, Pullen I, Whyte DA, Brock DJH (1992): Prenatal screening for cystic fibrosis. Lancet 340:214-216.
10. Miedzybrodzka ZH, Hall MH, Mollison J, Templeton A, Russell IT, Dean JC, Kelly KF, Marteau TM, Haites NE (1995): Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise versus couple screening. British Medical Journal 310:353-357.
11. Nesse RM, Klaas R (1994): Risk perception by patients with anxiety disorders. J Nerv Ment Dis 182:465-470.
12. Redelmeier DA, Rozin P, Kahneman D (1993): Understanding patients' decisions. Cognitive and emotional perspectives. Journal of the American Medical Association 270:72-76.
13. Siegel S, Castellan N (1988): Nonparametric Statistics for the behavioural sciences. McGraw Hill.
14. Surh LC, Cappelli M, MacDonald NE, Mettler G, Dales RE (1994): Cystic fibrosis carrier screening in a high-risk population: Participation based on a traditional recruitment process. Am J Dis Child 148:632-637.
15. Tsui LC (1994): The spectrum of cystic fibrosis mutations. Trends In Genetics 8:392-398.
16. Watson EK, Mayall ES, Lamb J, Chapple J, Williamson R (1992): Psychological and social consequences of a community carrier screening programme for cystic fibrosis. Lancet 340:217-220.
17. Weinstein ND (1989): Optimistic biases about personal risks. Science 246: 1232-1233.
18. Welkenhuysen M, Evers-Kiebooms G, Decruyenaere M, Van den Berghe H (1996): Unrealistic optimism and genetic risk. Psychology and Health 11:479-492.
19. Wilfond BJ, Fost N (1992): The introduction of Cystic Fibrosis carrier screening into clinical practice: policy considerations. The Milbank Quarterly 70:629-659.